Three-Dimensional Tomographic Imaging and Characterization of Iron Compounds within Alzheimer's Plaque Core Material
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Although it has been known for over 50 years that abnormal concentrations of iron are associated with virtually all neurodegenerative diseases, including Alzheimer's disease, its origin, nature and role have remained a mystery. Here, we use high-resolution transmission electron microscopy (HR-TEM), energy dispersive X-ray (EDX) spectroscopy and electron energy-loss spectroscopy (EELS), electron tomography, and electron diffraction to image and characterize iron-rich plaque core material - a hallmark of Alzheimer's disease pathology - in three dimensions. In these cores, we unequivocally identify biogenic magnetite and/or maghemite as the dominant iron compound. Our results provide an indication that abnormal iron biomineralization processes are likely occurring within the plaque or the surrounding diseased tissue and may play a role in aberrant peptide aggregation. The size distribution of the magnetite cores implies formation from a ferritin precursor, implicating a malfunction of the primary iron storage protein in the brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the location of iron in plaques has also been observed, for instance, for Alzheimer’s (e.g. Collingwood et al. 2008; Connor et al. 1992; El Tannir El Tayara et al. 2006; Ghribi et al. 2006; Haacke et al. 2005; Lovell et al. 1998; Morgan et al. 2004; Quintana 2007; Quintana et al. 2006; Sayre et al. 2000b; Schrag et al. 2009), ALS (Leveugle et al. 1997), MS (Haacke et al. 2009) and Parkinson’s (see”
From Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples (2010) · cites this paper as Collingwood et al. 2008
Citations
Cites
Electron Energy-Loss Spectroscopy in the Electron Microscope
Egerton, R. F., & Newbury, D. E. (1987) · Physics Today · doi:10.1063/1.2820276 · Cited by 3,415
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801 · cited 4×
“However, evidence is mounting that synergistic mechanisms are likely to exist between iron and amyloid-β (Aβ42 )– the principal component of senile plaques in AD – and other disease-related proteins [5,26,34,39,50, 58 ].”
BackgroundInfluentialIron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355 · cited 1×
“The association of redox-active iron with AD senile plaques has been indicated using a modified histochemical stain [54], and quantification of iron in senile plaque cores, corona, and surrounding neuropil has been undertaken using micro particle-induced Xray emission (microPIXE) to analyze fixed immunostained AD tiss…”
MethodSelf-citationMineralization in ferritin: an efficient means of iron storage
Chasteen, N. D., & Harrison, P. M. (1999) · Journal of Structural Biology · doi:10.1006/jsbi.1999.4118 · Cited by 815 · cited 1×
“If the biogenic magnetite/maghemite observed in this study is forming from a ferritin/ferrihydrite precursor, then one potential mechanism for its formation is a disruption of the ferritin protein’s ability to oxidize ferrous iron as it is transported into the internal cavity [8,10,45].”
BackgroundMagnetite biomineralization in the human brain.
Kirschvink, J. L., Kobayashi-Kirschvink, A., & Woodford, B. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7683 · Cited by 614 · cited 2×
“[36] shows magnetite/maghemite concentrations in the ng/g range.”
BackgroundDirect imaging of single-walled carbon nanotubes in cells
Porter, A. E., Gass, M., Muller, K., Skepper, J. N., Midgley, P. A., & Welland, M. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.347 · Cited by 564 · cited 1×
“HAADF scanning transmission electron microscopy (STEM) tomographic imaging has been shown to cause less damage to organic materials than broad beam techniques such as conventional bright-field imaging [20, 44].”
Dong, J., Atwood, C. S., Anderson, V. E., Siedlak, S. L., Smith, M. A., Perry, G., & Carey, P. R. (2003) · Biochemistry · doi:10.1021/bi0272151 · Cited by 562 · cited 4×
“The protein composition and conformation of extracted AD plaque core material has been investigated in detail using Ramen spectroscopy [15], demonstrating the dominance of the Aβ42 peptide, but it has not proved straightforward to determine the structural properties of the dense core region.”
BackgroundMethodResultInfluentialSelf-citationEffects of weak magnetic fields on free radical recombination reactions
Timmel, C. R., Till, U., Brocklehurst, B., Mclauchlan, K. A., & Hore, P. J. (1998) · Molecular Physics · doi:10.1080/00268979809483134 · Cited by 392 · cited 1×
“reaction rates and produce free radicals via triplet state stabilization [52,55].”
BackgroundRedox-active iron mediates amyloid-β toxicity
Rottkamp, C. A., Raina, A. K., Zhu, X., Gaier, E., Bush, A. I., Atwood, C. S., Chevion, M., Perry, G., & Smith, M. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00494-9 · Cited by 375 · cited 2×
“However, evidence is mounting that synergistic mechanisms are likely to exist between iron and amyloidβ (Aβ42) – the principal component of senile plaques in AD – and other disease-related proteins [5,26,34,39,50,58].”
BackgroundSelf-citation
Cited by
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
“Iron has also been found in the core of the senile plaques [68].”
BackgroundIn Situ Imaging of Metals in Cells and Tissues
McRae, R., Bagchi, P., Sumalekshmy, S., & Fahrni, C. J. (2009) · Chemical Reviews · doi:10.1021/cr900223a · Cited by 570
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“Developing novel pharmaceutical agents is a costly enter- prise, and many candidate drugs fall by the wayside during the development process (see e.g. Dobson et al. 2009b; Kola and Landis 2004; Leeson and Springthorpe 2007).”
BackgroundInfluentialMetallostasis in Alzheimer's disease
Ayton, S., Lei, P., & Bush, A. I. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.558 · Cited by 352
Iron and Alzheimer’s Disease: An Update on Emerging Mechanisms
Lane, D. J. R., Ayton, S., & Bush, A. I. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179944 · Cited by 276
Cell Uptake and in Vitro Toxicity of Magnetic Nanoparticles Suitable for Drug Delivery
Häfeli, U. O., Riffle, J. S., Harris-Shekhawat, L., Carmichael-Baranauskas, A., Mark, F., Dailey, J. P., & Bardenstein, D. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900083m · Cited by 277
Chen, L.-L., Fan, Y.-G., Zhao, L.-X., Zhang, Q., & Wang, Z.-Y. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106301 · Cited by 200
Understanding Aspects of Aluminum Exposure in Alzheimer's Disease Development
Kandimalla, R., Vallamkondu, J., Corgiat, E. B., & Gill, K. D. (2016) · Brain Pathology · doi:10.1111/bpa.12333 · Cited by 183
“(2008) Potential pathogenic role of beta-amyloid(1-42)-aluminum”
BackgroundInfluentialIron toxicity in neurodegeneration
Núñez, M. T., Urrutia, P., Mena, N., Aguirre, P., Tapia, V., & Salazar, J. (2012) · BioMetals · doi:10.1007/s10534-012-9523-0 · Cited by 180
“1997; Barnham and Bush 2008), that major neurodegenerative disorders such as AD and Parkinson’s disease are characterized by elevated tissue iron (Thompson et al. 2001; Collingwood et al. 2005; Collingwood et al. 2008; Barnham and Bush 2008) and that excess iron is a strong promoter of oxidative stress, it is of relev…”
BackgroundMeadowcroft, M. D., Connor, J. R., Smith, M. B., & Yang, Q. X. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21731 · Cited by 176
“Focal regions of high iron that are not associated with A plaques can be attributed to locations high in iron such as capillary vessels, hemosiderin (degraded ferritin) or regions of iron oxide (magnetite, hematite or wüstite) deposition (blue arrows) (10,11).”
BackgroundSelf-citationBusser, B., Moncayo, S., Coll, J.-L., Sancey, L., & Motto-Ros, V. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.12.006 · Cited by 172
Telling, N. D., Everett, J., Collingwood, J. F., Dobson, J., van der Laan, G., Gallagher, J. J., Wang, J., & Hitchcock, A. P. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.07.014 · Cited by 169
“For example we found that ferric iron was associated with diffuse plaques which are historically described as earlystage pathological structures (Selkoe, 1994), whereas more particulate and crystalline iron (such as magnetite) was commonly found within dense amorphous regions resembling plaque cores in the transgenic…”
BackgroundResultInfluentialSelf-citationYumoto, S., Kakimi, S., Ohsaki, A., & Ishikawa, A. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.07.023 · Cited by 166
Plascencia-Villa, G., Ponce, A., Collingwood, J. F., Arellano-Jiménez, M. J., Zhu, X., Rogers, J. T., Betancourt, I., José-Yacamán, M., & Perry, G. (2016) · Scientific Reports · doi:10.1038/srep24873 · Cited by 150
“3B), similar electron dense regions in APC have previously been observed and identified to contain Fe, Al, Si, Cu, and trace amounts of other inorganic elements 26,32,33 .”
InfluentialSelf-citationMyhre, O., Utkilen, H., Duale, N., Brunborg, G., & Hofer, T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/726954 · Cited by 152
Everett, J., Céspedes, E., Shelford, L. R., Exley, C., Collingwood, J. F., Dobson, J., van der Laan, G., Jenkins, C. A., Arenholz, E., & Telling, N. D. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0165 · Cited by 151
Self-citationZeineh, M. M., Chen, Y., Kitzler, H. H., Hammond, R., Vogel, H., & Rutt, B. K. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.022 · Cited by 151
“…occurs in AD (Lovell et al., 1998; Smith et al., 1997), and rather than being mineralized as the typical storage form of Fe3þ within ferrihydrite, it is more composed of magnetite and wüstite, which both possess Fe2þ (Collingwood et al., 2008; Pankhurst et al., 2008; Quintana et al., 2004).”
Alzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 150
Peters, D. G., Connor, J. R., & Meadowcroft, M. D. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.007 · Cited by 146
Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease
Gleason, A. J., & Bush, A. I. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00954-y · Cited by 143
Mørup, S., Hansen, M. F., & Frandsen, C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374396-1.00036-2 · Cited by 150
Biometals and Their Therapeutic Implications in Alzheimer's Disease
Ayton, S., Lei, P., & Bush, A. I. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0312-z · Cited by 142
“[99–108].”
Walton, J. R. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-132204 · Cited by 123
“Aluminum is present in aged human neurons of ADrelevant brain regions [136] and in A plaques of AD brains [123, 209, 354].”
BackgroundMetal imaging in neurodegenerative diseases
Bourassa, M. W., & Miller, L. M. (2012) · Metallomics · doi:10.1039/c2mt20052j · Cited by 121
Cogswell, P. M., Wiste, H. J., Senjem, M. L., Gunter, J. L., Weigand, S. D., Schwarz, C. G., Arani, A., Therneau, T. M., Lowe, V. J., Knopman, D. S., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2020.117433 · Cited by 117
Everett, J., Collingwood, J. F., Tjendana-Tjhin, V., Brooks, J., Lermyte, F., Plascencia-Villa, G., Hands-Portman, I., Dobson, J., Perry, G., & Telling, N. D. (2018) · Nanoscale · doi:10.1039/c7nr06794a · Cited by 115
Self-citationRodrigue, K. M., Daugherty, A. M., Haacke, E. M., & Raz, N. (2013) · Cerebral Cortex · doi:10.1093/cercor/bhs139 · Cited by 98
“Iron accumulates in amyloid plaque in AD samples (Lovell et al. 1998; Collingwood et al. 2008) and has been observed within amyloid deposits in a transgenic mouse model of AD (Falangola et al.”
BackgroundBiogenic metallic elements in the human brain?
Everett, J., Lermyte, F., Brooks, J., Tjendana-Tjhin, V., Plascencia-Villa, G., Hands-Portman, I., Donnelly, J. M., Billimoria, K., Perry, G., Zhu, X., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf6707 · Cited by 94
“Many studies have used microfocus x-ray spectroscopy to characterize metal chemistry in human tissues (33, 46).”
BackgroundSelf-citationSwanson, M. E. V., Scotter, E. L., Smyth, L. C. D., Murray, H. C., Ryan, B., Turner, C., Faull, R. L. M., Dragunow, M., & Curtis, M. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01047-9 · Cited by 90
Antharam, V., Collingwood, J. F., Bullivant, J.-P., Davidson, M. R., Chandra, S., Mikhaylova, A., Finnegan, M. E., Batich, C., Forder, J. R., & Dobson, J. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.019 · Cited by 82
“…control; however, it is also possible that the hypo-intensity pixels relate to highly localised susceptibility artefacts that may include pathologic hallmarks of AD such as iron-rich deposits associated with microbleeds and/or senile plaques (Collingwood et al., 2008a; Meadowcroft et al., 2009).”
BackgroundMethodResultInfluentialSelf-citationCrespo, Â. C., Silva, B. D. R., Marques, L., Marcelino, E., Maruta, C., Costa, S., Timóteo, Â., Vilares, A., do Couto, F. S., Faustino, P., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.078 · Cited by 84
Effect of Cerebral Amyloid Angiopathy on Brain Iron, Copper, and Zinc in Alzheimer's Disease
Schrag, M., Crofton, A., Zabel, M., Jiffry, A., Kirsch, D., Dickson, A., Mao, X. W., Vinters, H. V., Domaille, D. W., Chang, C. J., et al. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101503 · Cited by 79
“While some A plaques in human brain contain no more iron than normal brain tissue (one study found 30% had no detectable iron), some plaques have been shown to contain high concentrations of a reactive iron oxide, magnetite [39, 40].”
BackgroundDifferential effects of age and history of hypertension on regional brain volumes and iron
Rodrigue, K. M., Haacke, E. M., & Raz, N. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.068 · Cited by 85
“In comparison to the neocortex and the striatum, the medial– temporal regions present additional difficulty in interpretation of T2* differences, because they may contain iron trapped in the amyloid plaques (Bartzokis et al., 2007; Collingwood et al., 2008; Quintana et al., 2006).”
Bartzokis, G., Lu, P. H., Tishler, T. A., Peters, D. G., Kosenko, A., Barrall, K. A., Finn, J. P., Villablanca, P., Laub, G., Altshuler, L. L., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1368 · Cited by 69
“Whether differences in ferritin iron reflect higher iron content per ferritin molecule as reported in some diseases like AD and PD [60,61], larger numbers of ferritin molecules, or other forms of iron particles [62, 63], is not directly discernable from the FDRI data and remains to be determined.”
Mapping Brain Metals to Evaluate Therapies for Neurodegenerative Disease
Popescu, B. F. G., & Nichol, H. K. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00149.x · Cited by 80
Everett, J., Céspedes, E., Shelford, L. R., Exley, C., Collingwood, J. F., Dobson, J., van der Laan, G., Jenkins, C. A., Arenholz, E., & Telling, N. D. (2014) · Inorganic Chemistry · doi:10.1021/ic402406g · Cited by 67
Self-citationBarbic, M. (2019) · eLife · doi:10.7554/elife.45807 · Cited by 67
A new approach to the ferritin iron core growth: influence of the H/L ratio on the core shape
López-Castro, J. D., Delgado, J. J., Perez-Omil, J. A., Gálvez, N., Cuesta, R., Watt, R. K., & Domínguez-Vera, J. M. (2012) · Dalton Trans. · doi:10.1039/c1dt11205h · Cited by 63
Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X‐ray fluorescence
Hopp, K., Popescu, B. F. G., McCrea, R. P. E., Harder, S. L., Robinson, C. A., Haacke, M. E., Rajput, A. H., Rajput, A., & Nichol, H. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22201 · Cited by 63
Ali, M. R. A., Abo‐Youssef, A. M., Messiha, B. A. S., & Khattab, M. M. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1234-6 · Cited by 64
“ROS is also released through catalysis from extracellular iron and copper ions attached to Aβ (Collingwood et al. 2008; Graham et al. 2014).”
Novel drug targets based on metallobiology of Alzheimer's disease
Bandyopadhyay, S., Huang, X., Lahiri, D. K., & Rogers, J. T. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.525352 · Cited by 63
“Dysfunction of ferritin with ferroxidase activity [38], particularly abundant in myelinated axons and oligodendrocyte processes, results in an increase of toxic brain Fe ions.”
BackgroundMetal Ion Binding to the Amyloid β Monomer Studied by Native Top-Down FTICR Mass Spectrometry
Lermyte, F., Everett, J., Lam, Y. P. Y., Wootton, C. A., Brooks, J., Barrow, M. P., Telling, N. D., Sadler, P. J., O’Connor, P. B., & Collingwood, J. F. (2019) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-019-02283-7 · Cited by 57
“has been suggested in the past that ferritin—a water-soluble protein complex and the primary Fe reservoir in the brain—might be the origin of the mixed oxidation state iron phases that have been identified in plaque core material extracted from Alzheimer’s disease brain tissue [33, 59].”
BackgroundSelf-citationHart, A. J., Quinn, P. D., Lali, F. V., Sampson, B., Skinner, J. A., Powell, J. J., Nolan, J., Tucker, K., Donell, S. T., Flanagan, A. M., et al. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.05.003 · Cited by 56
Pretorius, E., Bester, J., & Kell, D. B. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160318 · Cited by 62
Visanji, N. P., Collingwood, J. F., Finnegan, M. E., Tandon, A., House, E., & Hazrati, L.-N. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130197 · Cited by 55
“It should also be noted that other forms of bio-iron may contribute to IRM signal at 5 Kelvin (K), including neuromelanin-bound iron [10] and iron oxide deposits including magnetite which may be associated with pathologic features such as amyloid plaques [11, 12].”
Self-citationGorobets, O., Gorobets, S., & Koralewski, M. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s130565 · Cited by 69
Iron stored in ferritin is chemically reduced in the presence of aggregating Aβ(1-42)
Everett, J., Brooks, J., Lermyte, F., O’Connor, P. B., Sadler, P. J., Dobson, J., Collingwood, J. F., & Telling, N. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-67117-z · Cited by 55
Self-citationMetal and complementary molecular bioimaging in Alzheimer's disease
Braidy, N., Poljak, A., Marjo, C. E., Rutlidge, H., Rich, A. M., Jayasena, T., Inestrosa, N. C., & Sachdev, P. S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00138 · Cited by 57
“…diffraction, and tomography techniques have been used to identify the presence of biogenic magnetite and/or maghematite in the plaque cores, implicating the likely role of a novel biomineralization process to account for the accumulation of iron in Aβ plaques (Collingwood et al., 2005, 2008).”
MethodMeadowcroft, M. D., Connor, J. R., & Yang, Q. X. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00255 · Cited by 51
“A relationship between iron and amyloid plaques has been established in AD tissue (Smith et al., 1997; Collingwood et al., 2008; Meadowcroft et al., 2009; Ayton et al., 2013) and, to a lesser extent, in the APP/PS1 model (Jack et al., 2004; El Tannir El Tayara et al., 2006; Meadowcroft et al.,…”
BackgroundMethodInfluentialHofer, T., & Perry, G. L. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.06.005 · Cited by 52
Self-citationBulk, M., van der Weerd, L., Breimer, W., Lebedev, N., Webb, A., Goeman, J. J., Ward, R. J., Huber, M., Oosterkamp, T. H., & Bossoni, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-25021-7 · Cited by 46
The effect of iron in MRI and transverse relaxation of amyloid‐beta plaques in Alzheimer's disease
Meadowcroft, M. D., Peters, D. G., Dewal, R. P., Connor, J. R., & Yang, Q. X. (2015) · NMR in Biomedicine · doi:10.1002/nbm.3247 · Cited by 48
“The increased concentration of iron in the brain tissue of patients with Alzheimer’s disease (AD) has been well demonstrated (5,6), and a close association of iron with amyloid-beta (Aβ) plaques has been established in AD tissue (7,8).”
Wu, L., Xian, X., Tan, Z., Dong, F., Xu, G., Zhang, M., & Zhang, F. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03245-7 · Cited by 58
The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light
Collingwood, J. F., & Davidson, M. R. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00191 · Cited by 49
Self-citationJohnstone, D. M., & Milward, E. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06697.x · Cited by 49
Peters, D. G., Pollack, A. N., Cheng, K. C., Sun, D., Saido, T. C., Haaf, M., Yang, Q. X., Connor, J. R., & Meadowcroft, M. D. (2018) · Metallomics · doi:10.1039/c8mt00004b · Cited by 45
A ferromagnetic model for the action of electric and magnetic fields in cryopreservation
Kobayashi, A., & Kirschvink, J. L. (2013) · Cryobiology · doi:10.1016/j.cryobiol.2013.12.002 · Cited by 43
“Brain tissues in humans have been studied extensively [5,9–11,16,21,22,36], and magnetite deposits in specialized cells are extensive [24,25].”
BackgroundThorwald, M. A., Godoy-Lugo, J. A., Garcia, G., Silva, J. A., Kim, M., Christensen, A., Mack, W. J., Head, E., O’Day, P. A., Benayoun, B. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14541 · Cited by 49
Peroxidase-like activity of magnetoferritin
Melníková, L., Pospíšková, K., Mitróová, Z., Kopčanský, P., & Šafařík, I. (2013) · Microchimica Acta · doi:10.1007/s00604-013-1105-5 · Cited by 38
“Anyway, the size distribution of the magnetite and maghemite nanoparticles implies their formation from a ferritin precursor, implicating a malfunction of the primary iron storage protein in the brain [41].”
BackgroundMagnetic Nanocrystals in Organisms
Pósfai, M., & Dunin‐Borkowski, R. E. (2009) · Elements · doi:10.2113/gselements.5.4.235 · Cited by 37
Self-citationIron metabolism in diabetes-induced Alzheimer’s disease: a focus on insulin resistance in the brain
Chung, J. Y., Kim, H.-S., & Song, J. (2018) · BioMetals · doi:10.1007/s10534-018-0134-2 · Cited by 41
Sodium selenate regulates the brain ionome in a transgenic mouse model of Alzheimer’s disease
Zheng, L. P., Zhu, H., Wang, B.-T., Qiong-hui, Z., Du, X., Zheng, Y., Jiang, L., Ni, J., Zhang, Y., & Liu, Q. (2016) · Scientific Reports · doi:10.1038/srep39290 · Cited by 35
Brain iron deposits and lifespan cognitive ability
Hernández, M. D. C. V., Ritchie, S. J., Glatz, A., Allerhand, M. H., Maniega, S. M., Gow, A. J., Royle, N. A., Bastin, M. E., Starr, J. M., Deary, I. J., et al. (2015) · AGE · doi:10.1007/s11357-015-9837-2 · Cited by 37
“In our normal ageing cohort, these iron deposits tended to be found in the same brain regions in which iron accumulates in neurodegenerative diseases like Alzheimer’s and Parkinson’s (Collingwood et al. 2008; Vymazal et al. 1999).”
BackgroundNeuropathology of Alzheimer's Disease and its Variants
Duyckaerts, C., & Dickson, D. (2011) · Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders · doi:10.1002/9781444341256.ch10 · Cited by 34
Aerosolized Coal Fly Ash: Risk Factor for Neurodegenerative Disease
Whiteside, M., & Herndon, J. M. (2018) · Journal of Advances in Medicine and Medical Research · doi:10.9734/jammr/2018/40072 · Cited by 36
“core material including iron, aluminum and silicon [27].”
BackgroundResultEmerging Approaches to Investigate the Influence of Transition Metals in the Proteinopathies
Lermyte, F., Everett, J. L., Brooks, J., Bellingeri, F., Billimoria, K., Sadler, P. J., O’Connor, P. B., Telling, N. D., & Collingwood, J. F. (2019) · Cells · doi:10.3390/cells8101231 · Cited by 31
“, APP/PS1), there is evidence of a direct correspondence between amyloid deposition and iron deposition [14], while the distribution of iron in human amyloid deposits is far more heterogeneous [13,16].”
BackgroundSelf-citationFerritin microheterogeneity, subunit composition, functional, and physiological implications
Srivastava, A. K., Reutovich, A. A., Hunter, N. J., Arosio, P., & Bou‐Abdallah, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-46880-9 · Cited by 33
Kopáni, M., Miglierini, M. B., Lančok, A., Dekan, J., Čaplovičová, M., Jakubovský, J., Boča, R., & Mrázová, H. (2015) · BioMetals · doi:10.1007/s10534-015-9876-2 · Cited by 31
Ferritin and metallothionein: dangerous liaisons
Orihuela, R., Fernández, B., Palacios, Ò., Valero, E., Atrian, S., Watt, R. K., Dominguez-Vera, J. M., & Capdevila, M. (2011) · Chemical Communications · doi:10.1039/c1cc14819b · Cited by 31
Brain oxidative stress in rat with chronic iron or copper overload
Musacco-Sebio, R., Ferrarotti, N., Lairion, F., Saporito-Magriñá, C., Fuda, J. A., Torti, H., Boveris, A. D., & Repetto, M. G. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110799 · Cited by 30
Targeting Progressive Neuroaxonal Injury: Lessons from Multiple Sclerosis
Bar‐Or, A., Rieckmann, P., Traboulsee, A. L., & Yong, V. W. (2011) · CNS Drugs · doi:10.2165/11587820-000000000-00000 · Cited by 29
Sub-cellular In-situ Characterization of Ferritin(iron) in a Rodent Model of Spinal Cord Injury
Blissett, A. R., Deng, B., Wei, P. Y., Walsh, K. J., Ollander, B., Sifford, J., Sauerbeck, A. D., McComb, D. W., McTigue, D. M., & Agarwal, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-21744-9 · Cited by 30
The Physics of Geomagnetic-Field Transduction in Animals
Michael Winklhofer, A. (2009) · IEEE Transactions on Magnetics · doi:10.1109/tmag.2009.2017940 · Cited by 28
“Also, the magnetic properties of the amorphous platelets remain to be determined—preferentially with magnetic mapping techniques such as transmission X-ray microscopy, Lorentz microscopy, or off-axis electron holography [31]—in order to assess if they have the potential to”
BackgroundThe Irony of Iron: The Element with Diverse Influence on Neurodegenerative Diseases
Lee, S., & Kovács, G. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084269 · Cited by 33
“Observations of co-localization between iron and A β plaques at the cellular level further support this idea [72].”
BackgroundProbing Trace Elements in Human Tissues with Synchrotron Radiation
Gherase, M. R., & Fleming, D. E. B. (2019) · Crystals · doi:10.3390/cryst10010012 · Cited by 27
Wyroba, E., Suski, S., Miller, K., & Bartosiewicz, R. (2015) · Cellular & Molecular Biology Letters · doi:10.1515/cmble-2015-0028 · Cited by 26
“It was shown that the dominant iron compounds biogenic magnetite and maghemite were present in these plaques [38].”
BackgroundAmyloid A β 42 , a promoter of magnetite nanoparticle formation in Alzheimer’s disease
Tahirbegi, I. B., Pardo, W. A., Alvira, M., Mir, M., & Samitier, J. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/46/465102 · Cited by 27
Using the magnetoencephalogram to noninvasively measure magnetite in the living human brain
Khan, S., & Cohen, D. (2018) · Human Brain Mapping · doi:10.1002/hbm.24477 · Cited by 32
Archibald, S. J., Atkin, S. L., Bras, W., Diego‐Taboada, A., Mackenzie, G., Mosselmans, J. F. W., Nikitenko, S., Quinn, P. D., Thomas, M. F., & Young, N. A. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb21523g · Cited by 27
Wagner, M., Helfrich, M., Volz, S., Magerkurth, J., Blasel, S., Porto, L., Singer, O. C., Deichmann, R., Jurcoane, A., & Hattingen, E. (2015) · Neuroradiology · doi:10.1007/s00234-015-1565-x · Cited by 26
Magnetic mapping of iron in rodent spleen
Blissett, A. R., Ollander, B., Penn, B. M., McTigue, D. M., & Agarwal, G. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.11.011 · Cited by 25
Jiang, C., Zou, X., Zhu, R., Shi, Y.-M., Wu, Z., Zhao, F., & Chen, L. (2018) · Journal of neurosurgery · doi:10.3171/2018.1.jns172938 · Cited by 24
Iron Oxides in the Human Brain
Collingwood, J. F., & Telling, N. D. (2016) · Wiley eBooks · doi:10.1002/9783527691395.ch7 · Cited by 24
Self-citationCorrelative Microscopy to Localize and Characterize Iron Deposition in Alzheimer’s Disease
Madsen, S. J., DiGiacomo, P., Zeng, Y., Goubran, M., Chen, Y., Rutt, B. K., Born, D. E., Vogel, H. S., Sinclair, R., & Zeineh, M. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200234 · Cited by 23
Native and Synthetic Ferritins for Nanobiomedical Applications: Recent Advances and New Perspectives
Dominguez-Vera, J. M., Fernández, B., & Gálvez, N. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.09.171 · Cited by 21
Iron–oxide minerals in the human tissues
Svobodová, H., Kosnáč, D., Tanila, H., Wagner, A., Trnka, M., Vitovič, P., Hlinková, J., Vavrinský, E., Ehrlich, H., Polák, Š., et al. (2020) · BioMetals · doi:10.1007/s10534-020-00232-6 · Cited by 23
Nabuurs, R. J. A., Natté, R., de Ronde, F. M., Hegeman-Kleinn, I. M., Dijkstra, J., van Duinen, S. G., WEBB, A. G., Rozemüller, A. J. M., van Buchem, M. A., & van der Weerd, L. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122215 · Cited by 21
Identification of Ferrous-Ferric Fe3O4 Nanoparticles in Recombinant Human Ferritin Cages
Walls, M. G., Cao, C., Yu-Zhang, K., Li, J., Che, R., & Pan, Y. (2013) · Microscopy and Microanalysis · doi:10.1017/s1431927613001724 · Cited by 19
“; ~b! correlation with virtually all neurodegenerative diseases, including Alzheimer’s ~Lovell et al., 1998; Dobson, 2001a, 2001b; Quintana et al., 2004; Collingwood et al., 2008!”
BackgroundDiCecco, L., Tang, T., Sone, E. D., & Grandfield, K. (2024) · Small · doi:10.1002/smll.202407539 · Cited by 18
Biogenic magnetic nanoparticles in human organs and tissues
Gorobets, S. V., Medviediev, O., Gorobets, O., & Ivanchenko, A. B. (2018) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2018.01.010 · Cited by 18
Mohammadi, S., Ghaderi, S., & Fatehi, F. (2024) · Aging Medicine · doi:10.1002/agm2.12363 · Cited by 20
Sussulini, A., Matusch, A., Klietz, M., Bauer, A., Depboylu, C., & Becker, J. S. (2012) · Biomedical Spectroscopy and Imaging · doi:10.3233/bsi-2012-0011 · Cited by 17
“For example, µSR-XRF [19], PIXE (comparison of lesioned SN versus the healthy side in 7 6-OHDA rats and 8 controls) [24], nanoSIMS [46], LMD-ICP-MS [5], EFTEM/EELS [16,41], EM-EDS [16] were applied for questions involving subareas of a brain section and the characterisation of single cells.”
Impact of Iron Incorporation on 2–4 nm Size Silicon Nanoparticles Properties
Romero, J. J., Wegmann, M., Rodríguez, H. B., Lillo, C. R., Rubert, A. A., Klein, S., Kotler, M. L., Kryschi, C., & Gonzalez, M. C. (2015) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.5b00172 · Cited by 16
Xiao, W., Jones, A. M., Collins, R. N., & Waite, T. D. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.05.005 · Cited by 16
In vitro study of magnetite-amyloid β complex formation
Mir, M., Tahirbegi, I. B., Valle‐Delgado, J. J., Fernàndez‐Busquets, X., & Samitier, J. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.11.010 · Cited by 15
Narayanan, S., Shahbazian‐Yassar, R., & Shokuhfar, T. (2019) · Journal of Physics D Applied Physics · doi:10.1088/1361-6463/ab353b · Cited by 14
“While EDS was utilized to identify the presence of iron in the core [115, 116], EELS was first used to study the distinction between the iron cores extracted from a healthy brain and the”
MethodChain‐Like Structures of Biogenic and Nonbiogenic Magnetic Nanoparticles in Vascular Tissues
Gorobets, S., Gorobets, O., Gorobets, Y. I., & Bulaievska, M. (2022) · Bioelectromagnetics · doi:10.1002/bem.22390 · Cited by 13
Johnstone, D. M., Graham, R. M., Trinder, D., Riveros, C., Olynyk, J. K., Scott, R. J., Moscato, P., & Milward, E. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112183 · Cited by 14
“Iron abnormalities have also been detected in brains of Alzheimer’s disease (AD) patients using various different techniques, including histochemical staining for iron [7, 8], magnetic resonance imaging [9, 10], and spectroscopic, tomographic, and related techniques [11].”
Label-Free In Situ Chemical Characterization of Amyloid Plaques in Human Brain Tissues
Everett, J. L., Brooks, J., Tjhin, V. T., Lermyte, F., Hands-Portman, I., Plascencia‐Villa, G., Perry, G. L., Sadler, P. J., O’Connor, P. B., Collingwood, J. F., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00756 · Cited by 13
“31,62 The Fe 0 reference spectrum used for fitting was obtained from Fe 0 film standards prepared and measured under vacuum to prevent oxidation.”
BackgroundMethodSelf-citationStructural characterization of magnetoferritin
Melníková, L., Mitróová, Z., Timko, M., Kováč, J., Avdeev, M. V., Petrenko, V. I., Garamus, V. M., Almásy, L., & Kopčanský, P. (2014) · Mendeleev Communications · doi:10.1016/j.mencom.2014.03.004 · Cited by 11
Metadata
- Authors
- Collingwood, J. F., Chong, R. K. K., Kasama, T., Cervera-Gontard, L., Dunin-Borkowski, R. E., Perry, G., Pósfai, M., Siedlak, S. L., Simpson, E. T., Smith, M. A., & Dobson, J.
- Affiliations
- Keele University (GB)
- University of Cambridge (GB)
- Department of Materials Science and Metallurgy, University of Cambridge, Pembroke Street, Cambridge, CB2, 3QZ, UK
- The University of Texas at San Antonio (US)
- University of Pannonia (HU)
- Case Western Reserve University (US)
- Corresponding author
- Dobson, Jon
- ORCID
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2008-06-04
- Volume
- 14
- Issue
- 2
- Pages
- 235-245
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1674883404
- Cited by
- 147
- References
- 52
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 7 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 9 · 2019: 9 · 2018: 18 · 2017: 7 · 2016: 10 · 2015: 11 · 2014: 8 · 2013: 9 · 2012: 8
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
- RODIN (Universidad de Cádiz) (submittedVersion, cc-by-nc-nd)
- University of Warwick (cc-by)
- Funders
- Royal Society
- Research Councils UK
- National Institutes of Health
- Engineering and Physical Sciences Research Council (EP/D066654/1)
- National Institute on Aging (R01 AG 02030-01)
- National Institute of Neurological Disorders and Stroke (R21NS060304)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Alzheimer's disease, amyloid plaques
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Cerebral Cortex, Electron Probe Microanalysis, Humans, Image Processing, Computer-Assisted, Microscopy, Electron, Imaging, Three-Dimensional, Ferrosoferric Oxide, Iron Compounds, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.